- Home
- CELC vs NOG Comparison
CELC vs NOG Comparison
Compare CELC & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- NOG
- Stock Information
- Founded
- CELC 2011
- NOG 2006
- Country
- CELC United States
- NOG United States
- Employees
- CELC N/A
- NOG N/A
- Industry
- CELC Medical Specialities
- NOG Oil & Gas Production
- Sector
- CELC Health Care
- NOG Energy
- Exchange
- CELC Nasdaq
- NOG Nasdaq
- Market Cap
- CELC 2.3B
- NOG 2.6B
- IPO Year
- CELC 2017
- NOG N/A
- Fundamental
- Price
- CELC $51.88
- NOG $21.54
- Analyst Decision
- CELC Strong Buy
- NOG Buy
- Analyst Count
- CELC 5
- NOG 8
- Target Price
- CELC $67.20
- NOG $31.00
- AVG Volume (30 Days)
- CELC 1.1M
- NOG 2.2M
- Earning Date
- CELC 11-13-2025
- NOG 11-06-2025
- Dividend Yield
- CELC N/A
- NOG 8.34%
- EPS Growth
- CELC N/A
- NOG 6.84
- EPS
- CELC N/A
- NOG 6.08
- Revenue
- CELC N/A
- NOG $2,094,039,000.00
- Revenue This Year
- CELC N/A
- NOG $18.65
- Revenue Next Year
- CELC N/A
- NOG N/A
- P/E Ratio
- CELC N/A
- NOG $3.55
- Revenue Growth
- CELC N/A
- NOG 6.25
- 52 Week Low
- CELC $7.58
- NOG $19.88
- 52 Week High
- CELC $63.06
- NOG $44.31
- Technical
- Relative Strength Index (RSI)
- CELC 53.91
- NOG 33.47
- Support Level
- CELC $45.15
- NOG $22.05
- Resistance Level
- CELC $50.00
- NOG $25.06
- Average True Range (ATR)
- CELC 3.48
- NOG 0.95
- MACD
- CELC -0.04
- NOG -0.38
- Stochastic Oscillator
- CELC 64.67
- NOG 8.55
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).